BAUSCH AND LOMB
Home
Mapa do site
Sobre a B&L
Contato
Log In Vision Care Surgical Pharmaceuticals
Bausch and Lomb: Lotemax Frequently asked questions
What is a "site-specific" steroid? What is the difference between an ester and a ketone steroid?
Why hasn't B&L compared Lotemax to Allergan's Pred Forte® in post-op inflammation? What role do you see for Lotemax in acute anterior uveitis?
Isn't Lotemax just another "me-too" to Alcon's Vexol®? Is Lotemax just another FML®?
How is Lotemax different from an NSAID like Voltaren® or Acular®? How is Lotemax dosed/prescribed?
How is Lotemax priced?    
What is a "site-specific" steroid?
Lotemax was specifically designed to reach the sites of ocular inflammation in the cornea, iris, and ciliary body. There, it exerts its anti-inflammatory effect and is then metabolized by naturally occurring esterases into an inactive metabolite. The result is efficacy with a low incidence of side effects1 such as elevated intraocular pressure.
Back to top
What is the difference between an ester and a ketone steroid?
Loteprednol is the only ester steroid currently on the market. All other available ocular steroids (prednisolone, fluorometholone, rimexolone, dexamethasone) are ketone steroids. Ketone steroids are not broken down by esterases. As a result they have a propensity to remain in the anterior chamber.
Back to top
Why hasn't B&L compared Lotemax to Allergan's Pred Forte® in post-op inflammation?
Pred Forte® does not have an FDA-approved indication for post-operative inflammation in its product labeling. The FDA will not allow companies to compare a product that has an indication for a condition against one that does not have a similar indication for the same condition.
Back to top
What role do you see for Lotemax in acute anterior uveitis?
Lotemax has demonstrated efficacy against acute anterior uveitis and would be appropriate for mild to moderate cases or in patients who are steroid responders.
Back to top
Isn't Lotemax just another "me-too" to Alcon's Vexol®?
The unique design and metabolism of Lotemax differentiates it from other steroids.
Lotemax is predictably transformed to an inactive metabolite based on the "site specific" principles from Dr. Nicholas Bodor (also known as retrometabolic drug design)1, 2
Lotemax has an ester group on the #20 carbon structure; Vexol has a ketone structure
Lotemax has obtained class labeling from the FDA, allowing it to be used to treat eye inflammation that is responsive to ophthalmic steroids (i.e. SAC, GPC, acute anterior uveitis); Lotemax is also indicated for the treatment of post-operative inflammation following ocular surgery. Vexol does not have class labeling and is only indicated for post-op and anterior uveitis
Back to top
Is Lotemax just another FML®?
Lotemax is an ester steroid; FML is a ketone steroid. Both Lotemax and FML contain class labeling in their package inserts. Lotemax also has an indication for post-op inflammation in their labeling. Currently, FML does not have an indication for post-op inflammation.
Back to top
How is Lotemax different from an NSAID like Voltaren® or Acular®?
Steroids are broad acting anti-inflammatories that affect a wide array of mediators whereas NSAIDs work primarily via the cyclooxygenase pathway.
Back to top
How is Lotemax dosed/prescribed?
Steroid responsive disease treatment:
Apply 1 to 2 drops of Lotemax into the conjunctival sac of the affected eye(s) four times daily. During the initial treatment within the first week, the dosing may be increased, up to 1 drop every hour, if necessary. Care should be taken not to discontinue therapy prematurely. If signs and symptoms fail to improve after two days, the patient should be re-evaluated.

Post-operative inflammation:
Apply 1 to 2 drops of Lotemax into the conjunctival sac of the operated eye(s) four times daily beginning 24 hours after surgery and continuing throughout the first two weeks of the post-operative period.

Back to top
How is Lotemax priced?
Lotemax is competitively priced among all branded ophthalmic steroids3. Lotemax is usually less expensive than branded NSAIDs. As prices will vary geographically, please check prices locally.
Back to top
Bausch and Lomb The inside story
Lotemax® (loteprednol etabonate ophthalmic suspension 0.5%) offers the broadest range of indications of any ophthalmic steroid currently available.

Novel compound with a unique, site-specific mechanism of action
Get the answers to your questions about Lotemax
Proven effective in clinical studies
Impressive safety profile includes a low incidence of IOP elevation
Safety Information
Package Insert

Legal Notice | Privacy Policy | © |

 

1 Bodor N. Adv Drug Res. 1984; 13: 255 - 331
2 Bodor N. Med Res Rev. 1984; 4: 449 - 469
3 Red Book, September 2000